The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Therapeutics Market Research Report 2025
Synopsis
Veterinary Therapeutics are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global Veterinary Therapeutics market was valued at US$ 23720 million in 2023 and is anticipated to reach US$ 34600 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
North American market for Veterinary Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Veterinary Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Veterinary Therapeutics in Pets is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Veterinary Therapeutics include Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra and Norbrook, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Veterinary Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Therapeutics.
Report Scope
The Veterinary Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Pets
Cattle
Poultry
Swine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Veterinary Therapeutics are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global Veterinary Therapeutics market was valued at US$ 23720 million in 2023 and is anticipated to reach US$ 34600 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
North American market for Veterinary Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Veterinary Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Veterinary Therapeutics in Pets is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Veterinary Therapeutics include Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra and Norbrook, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Veterinary Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Therapeutics.
Report Scope
The Veterinary Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Segment by Application
Pets
Cattle
Poultry
Swine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
1.3 Market by Application
1.3.1 Global Veterinary Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pets
1.3.3 Cattle
1.3.4 Poultry
1.3.5 Swine
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Therapeutics Market Perspective (2019-2030)
2.2 Veterinary Therapeutics Growth Trends by Region
2.2.1 Global Veterinary Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Veterinary Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Veterinary Therapeutics Market Dynamics
2.3.1 Veterinary Therapeutics Industry Trends
2.3.2 Veterinary Therapeutics Market Drivers
2.3.3 Veterinary Therapeutics Market Challenges
2.3.4 Veterinary Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Therapeutics Players by Revenue
3.1.1 Global Top Veterinary Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Therapeutics Revenue
3.4 Global Veterinary Therapeutics Market Concentration Ratio
3.4.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2023
3.5 Veterinary Therapeutics Key Players Head office and Area Served
3.6 Key Players Veterinary Therapeutics Product Solution and Service
3.7 Date of Enter into Veterinary Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Therapeutics Breakdown Data by Type
4.1 Global Veterinary Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2025-2030)
5 Veterinary Therapeutics Breakdown Data by Application
5.1 Global Veterinary Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Therapeutics Market Size (2019-2030)
6.2 North America Veterinary Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Veterinary Therapeutics Market Size by Country (2019-2024)
6.4 North America Veterinary Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Therapeutics Market Size (2019-2030)
7.2 Europe Veterinary Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Veterinary Therapeutics Market Size by Country (2019-2024)
7.4 Europe Veterinary Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Veterinary Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Veterinary Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Therapeutics Market Size (2019-2030)
9.2 Latin America Veterinary Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Veterinary Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Veterinary Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Veterinary Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Veterinary Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Veterinary Therapeutics Introduction
11.1.4 Zoetis Revenue in Veterinary Therapeutics Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Elanco
11.2.1 Elanco Company Detail
11.2.2 Elanco Business Overview
11.2.3 Elanco Veterinary Therapeutics Introduction
11.2.4 Elanco Revenue in Veterinary Therapeutics Business (2019-2024)
11.2.5 Elanco Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Veterinary Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Veterinary Therapeutics Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Veterinary Therapeutics Introduction
11.4.4 Merck Revenue in Veterinary Therapeutics Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Virbac
11.5.1 Virbac Company Detail
11.5.2 Virbac Business Overview
11.5.3 Virbac Veterinary Therapeutics Introduction
11.5.4 Virbac Revenue in Veterinary Therapeutics Business (2019-2024)
11.5.5 Virbac Recent Development
11.6 Ceva
11.6.1 Ceva Company Detail
11.6.2 Ceva Business Overview
11.6.3 Ceva Veterinary Therapeutics Introduction
11.6.4 Ceva Revenue in Veterinary Therapeutics Business (2019-2024)
11.6.5 Ceva Recent Development
11.7 Vetoquinol
11.7.1 Vetoquinol Company Detail
11.7.2 Vetoquinol Business Overview
11.7.3 Vetoquinol Veterinary Therapeutics Introduction
11.7.4 Vetoquinol Revenue in Veterinary Therapeutics Business (2019-2024)
11.7.5 Vetoquinol Recent Development
11.8 Dechra
11.8.1 Dechra Company Detail
11.8.2 Dechra Business Overview
11.8.3 Dechra Veterinary Therapeutics Introduction
11.8.4 Dechra Revenue in Veterinary Therapeutics Business (2019-2024)
11.8.5 Dechra Recent Development
11.9 Norbrook
11.9.1 Norbrook Company Detail
11.9.2 Norbrook Business Overview
11.9.3 Norbrook Veterinary Therapeutics Introduction
11.9.4 Norbrook Revenue in Veterinary Therapeutics Business (2019-2024)
11.9.5 Norbrook Recent Development
11.10 Phibro
11.10.1 Phibro Company Detail
11.10.2 Phibro Business Overview
11.10.3 Phibro Veterinary Therapeutics Introduction
11.10.4 Phibro Revenue in Veterinary Therapeutics Business (2019-2024)
11.10.5 Phibro Recent Development
11.11 Huvepharma
11.11.1 Huvepharma Company Detail
11.11.2 Huvepharma Business Overview
11.11.3 Huvepharma Veterinary Therapeutics Introduction
11.11.4 Huvepharma Revenue in Veterinary Therapeutics Business (2019-2024)
11.11.5 Huvepharma Recent Development
11.12 Hipra
11.12.1 Hipra Company Detail
11.12.2 Hipra Business Overview
11.12.3 Hipra Veterinary Therapeutics Introduction
11.12.4 Hipra Revenue in Veterinary Therapeutics Business (2019-2024)
11.12.5 Hipra Recent Development
11.13 Ouro Fino Saude
11.13.1 Ouro Fino Saude Company Detail
11.13.2 Ouro Fino Saude Business Overview
11.13.3 Ouro Fino Saude Veterinary Therapeutics Introduction
11.13.4 Ouro Fino Saude Revenue in Veterinary Therapeutics Business (2019-2024)
11.13.5 Ouro Fino Saude Recent Development
11.14 CAHIC
11.14.1 CAHIC Company Detail
11.14.2 CAHIC Business Overview
11.14.3 CAHIC Veterinary Therapeutics Introduction
11.14.4 CAHIC Revenue in Veterinary Therapeutics Business (2019-2024)
11.14.5 CAHIC Recent Development
11.15 Orion
11.15.1 Orion Company Detail
11.15.2 Orion Business Overview
11.15.3 Orion Veterinary Therapeutics Introduction
11.15.4 Orion Revenue in Veterinary Therapeutics Business (2019-2024)
11.15.5 Orion Recent Development
11.16 Ringpu Biology
11.16.1 Ringpu Biology Company Detail
11.16.2 Ringpu Biology Business Overview
11.16.3 Ringpu Biology Veterinary Therapeutics Introduction
11.16.4 Ringpu Biology Revenue in Veterinary Therapeutics Business (2019-2024)
11.16.5 Ringpu Biology Recent Development
11.17 Nippon Zenyaku Kogyo
11.17.1 Nippon Zenyaku Kogyo Company Detail
11.17.2 Nippon Zenyaku Kogyo Business Overview
11.17.3 Nippon Zenyaku Kogyo Veterinary Therapeutics Introduction
11.17.4 Nippon Zenyaku Kogyo Revenue in Veterinary Therapeutics Business (2019-2024)
11.17.5 Nippon Zenyaku Kogyo Recent Development
11.18 Farmavet-Pasteur
11.18.1 Farmavet-Pasteur Company Detail
11.18.2 Farmavet-Pasteur Business Overview
11.18.3 Farmavet-Pasteur Veterinary Therapeutics Introduction
11.18.4 Farmavet-Pasteur Revenue in Veterinary Therapeutics Business (2019-2024)
11.18.5 Farmavet-Pasteur Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Anti-Infectives
Table 3. Key Players of Anti-Inflammatory
Table 4. Key Players of Parasiticides
Table 5. Key Players of Analgesics
Table 6. Key Players of Sedatives
Table 7. Key Players of Others
Table 8. Global Veterinary Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Veterinary Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Veterinary Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Veterinary Therapeutics Market Share by Region (2019-2024)
Table 12. Global Veterinary Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Veterinary Therapeutics Market Share by Region (2025-2030)
Table 14. Veterinary Therapeutics Market Trends
Table 15. Veterinary Therapeutics Market Drivers
Table 16. Veterinary Therapeutics Market Challenges
Table 17. Veterinary Therapeutics Market Restraints
Table 18. Global Veterinary Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Veterinary Therapeutics Market Share by Players (2019-2024)
Table 20. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2023)
Table 21. Ranking of Global Top Veterinary Therapeutics Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Veterinary Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Veterinary Therapeutics Product Solution and Service
Table 25. Date of Enter into Veterinary Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Veterinary Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Veterinary Therapeutics Revenue Market Share by Type (2019-2024)
Table 29. Global Veterinary Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Veterinary Therapeutics Revenue Market Share by Type (2025-2030)
Table 31. Global Veterinary Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Veterinary Therapeutics Revenue Market Share by Application (2019-2024)
Table 33. Global Veterinary Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Veterinary Therapeutics Revenue Market Share by Application (2025-2030)
Table 35. North America Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Veterinary Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Veterinary Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Veterinary Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Veterinary Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Veterinary Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Veterinary Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Veterinary Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Veterinary Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Veterinary Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Veterinary Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Veterinary Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 50. Zoetis Company Detail
Table 51. Zoetis Business Overview
Table 52. Zoetis Veterinary Therapeutics Product
Table 53. Zoetis Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 54. Zoetis Recent Development
Table 55. Elanco Company Detail
Table 56. Elanco Business Overview
Table 57. Elanco Veterinary Therapeutics Product
Table 58. Elanco Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 59. Elanco Recent Development
Table 60. Boehringer Ingelheim Company Detail
Table 61. Boehringer Ingelheim Business Overview
Table 62. Boehringer Ingelheim Veterinary Therapeutics Product
Table 63. Boehringer Ingelheim Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 64. Boehringer Ingelheim Recent Development
Table 65. Merck Company Detail
Table 66. Merck Business Overview
Table 67. Merck Veterinary Therapeutics Product
Table 68. Merck Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Virbac Company Detail
Table 71. Virbac Business Overview
Table 72. Virbac Veterinary Therapeutics Product
Table 73. Virbac Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 74. Virbac Recent Development
Table 75. Ceva Company Detail
Table 76. Ceva Business Overview
Table 77. Ceva Veterinary Therapeutics Product
Table 78. Ceva Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 79. Ceva Recent Development
Table 80. Vetoquinol Company Detail
Table 81. Vetoquinol Business Overview
Table 82. Vetoquinol Veterinary Therapeutics Product
Table 83. Vetoquinol Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 84. Vetoquinol Recent Development
Table 85. Dechra Company Detail
Table 86. Dechra Business Overview
Table 87. Dechra Veterinary Therapeutics Product
Table 88. Dechra Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 89. Dechra Recent Development
Table 90. Norbrook Company Detail
Table 91. Norbrook Business Overview
Table 92. Norbrook Veterinary Therapeutics Product
Table 93. Norbrook Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 94. Norbrook Recent Development
Table 95. Phibro Company Detail
Table 96. Phibro Business Overview
Table 97. Phibro Veterinary Therapeutics Product
Table 98. Phibro Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 99. Phibro Recent Development
Table 100. Huvepharma Company Detail
Table 101. Huvepharma Business Overview
Table 102. Huvepharma Veterinary Therapeutics Product
Table 103. Huvepharma Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 104. Huvepharma Recent Development
Table 105. Hipra Company Detail
Table 106. Hipra Business Overview
Table 107. Hipra Veterinary Therapeutics Product
Table 108. Hipra Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 109. Hipra Recent Development
Table 110. Ouro Fino Saude Company Detail
Table 111. Ouro Fino Saude Business Overview
Table 112. Ouro Fino Saude Veterinary Therapeutics Product
Table 113. Ouro Fino Saude Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 114. Ouro Fino Saude Recent Development
Table 115. CAHIC Company Detail
Table 116. CAHIC Business Overview
Table 117. CAHIC Veterinary Therapeutics Product
Table 118. CAHIC Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 119. CAHIC Recent Development
Table 120. Orion Company Detail
Table 121. Orion Business Overview
Table 122. Orion Veterinary Therapeutics Product
Table 123. Orion Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 124. Orion Recent Development
Table 125. Ringpu Biology Company Detail
Table 126. Ringpu Biology Business Overview
Table 127. Ringpu Biology Veterinary Therapeutics Product
Table 128. Ringpu Biology Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 129. Ringpu Biology Recent Development
Table 130. Nippon Zenyaku Kogyo Company Detail
Table 131. Nippon Zenyaku Kogyo Business Overview
Table 132. Nippon Zenyaku Kogyo Veterinary Therapeutics Product
Table 133. Nippon Zenyaku Kogyo Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 134. Nippon Zenyaku Kogyo Recent Development
Table 135. Farmavet-Pasteur Company Detail
Table 136. Farmavet-Pasteur Business Overview
Table 137. Farmavet-Pasteur Veterinary Therapeutics Product
Table 138. Farmavet-Pasteur Revenue in Veterinary Therapeutics Business (2019-2024) & (US$ Million)
Table 139. Farmavet-Pasteur Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Veterinary Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Anti-Infectives Features
Figure 4. Anti-Inflammatory Features
Figure 5. Parasiticides Features
Figure 6. Analgesics Features
Figure 7. Sedatives Features
Figure 8. Others Features
Figure 9. Global Veterinary Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Veterinary Therapeutics Market Share by Application: 2023 VS 2030
Figure 11. Pets Case Studies
Figure 12. Cattle Case Studies
Figure 13. Poultry Case Studies
Figure 14. Swine Case Studies
Figure 15. Others Case Studies
Figure 16. Veterinary Therapeutics Report Years Considered
Figure 17. Global Veterinary Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Veterinary Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Veterinary Therapeutics Market Share by Region: 2023 VS 2030
Figure 20. Global Veterinary Therapeutics Market Share by Players in 2023
Figure 21. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Veterinary Therapeutics Revenue in 2023
Figure 23. North America Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Veterinary Therapeutics Market Share by Country (2019-2030)
Figure 25. United States Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Veterinary Therapeutics Market Share by Country (2019-2030)
Figure 29. Germany Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Veterinary Therapeutics Market Share by Region (2019-2030)
Figure 37. China Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Veterinary Therapeutics Market Share by Country (2019-2030)
Figure 45. Mexico Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Veterinary Therapeutics Market Share by Country (2019-2030)
Figure 49. Turkey Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Veterinary Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Zoetis Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 52. Elanco Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 54. Merck Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 55. Virbac Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 56. Ceva Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 57. Vetoquinol Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 58. Dechra Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 59. Norbrook Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 60. Phibro Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 61. Huvepharma Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 62. Hipra Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 63. Ouro Fino Saude Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 64. CAHIC Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 65. Orion Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 66. Ringpu Biology Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 67. Nippon Zenyaku Kogyo Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 68. Farmavet-Pasteur Revenue Growth Rate in Veterinary Therapeutics Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
